Insulet Management
Management criteria checks 4/4
Insulet's CEO is Jim Hollingshead, appointed in Jun 2022, has a tenure of 2.42 years. total yearly compensation is $12.38M, comprised of 6.8% salary and 93.2% bonuses, including company stock and options. directly owns 0.025% of the company’s shares, worth $4.58M. The average tenure of the management team and the board of directors is 2.4 years and 4 years respectively.
Key information
Jim Hollingshead
Chief executive officer
US$12.4m
Total compensation
| CEO salary percentage | 6.8% |
| CEO tenure | 2.4yrs |
| CEO ownership | 0.02% |
| Management average tenure | 2.4yrs |
| Board average tenure | 4yrs |
Recent management updates
Recent updates
Insulet Corporation: Significant Opportunities, Significant Threats - I'm On The Sidelines
Nov 20Does This Valuation Of Insulet Corporation (NASDAQ:PODD) Imply Investors Are Overpaying?
Nov 20
Returns At Insulet (NASDAQ:PODD) Are On The Way Up
Nov 08Market Participants Recognise Insulet Corporation's (NASDAQ:PODD) Revenues
Oct 15Is There Now An Opportunity In Insulet Corporation (NASDAQ:PODD)?
Oct 03Is Insulet (NASDAQ:PODD) A Risky Investment?
Sep 09Insulet: Turning More Constructive, Valuations Still Stretched
Sep 05Here's Why We Think Insulet (NASDAQ:PODD) Is Well Worth Watching
Aug 28Additional Considerations Required While Assessing Insulet's (NASDAQ:PODD) Strong Earnings
Aug 16A Look At The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)
Jul 15Insulet Corporation: Insulin Pump Provider Fighting Back After Torrid 2023
Jun 11We Like These Underlying Return On Capital Trends At Insulet (NASDAQ:PODD)
May 26At US$166, Is It Time To Put Insulet Corporation (NASDAQ:PODD) On Your Watch List?
May 12Is Insulet (NASDAQ:PODD) A Risky Investment?
Apr 29Insulet Corporation's (NASDAQ:PODD) Earnings Haven't Escaped The Attention Of Investors
Apr 14Estimating The Fair Value Of Insulet Corporation (NASDAQ:PODD)
Mar 31Insulet: Insulating Patients, Investors Still Have To Wait
Mar 28Insulet (NASDAQ:PODD) Is Doing The Right Things To Multiply Its Share Price
Feb 19Is Insulet Corporation (NASDAQ:PODD) Potentially Undervalued?
Jan 22Insulet: An Interesting, Yet Expensive, Story
Jan 10Is Insulet (NASDAQ:PODD) Using Too Much Debt?
Jan 09Insulet Corporation's (NASDAQ:PODD) Earnings Haven't Escaped The Attention Of Investors
Dec 27Estimating The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)
Nov 14Insulet (NASDAQ:PODD) Shareholders Will Want The ROCE Trajectory To Continue
Oct 31We Think Insulet (NASDAQ:PODD) Is Taking Some Risk With Its Debt
Oct 01Is There Now An Opportunity In Insulet Corporation (NASDAQ:PODD)?
Sep 16Estimating The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)
Aug 14Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger
Jul 31Is Insulet (NASDAQ:PODD) Using Too Much Debt?
Jun 18Getting In Cheap On Insulet Corporation (NASDAQ:PODD) Might Be Difficult
May 22Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger
Apr 30Here's Why Insulet (NASDAQ:PODD) Has A Meaningful Debt Burden
Jan 24CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$421m |
| Jun 30 2024 | n/a | n/a | US$395m |
| Mar 31 2024 | n/a | n/a | US$234m |
| Dec 31 2023 | US$12m | US$842k | US$206m |
| Sep 30 2023 | n/a | n/a | US$120m |
| Jun 30 2023 | n/a | n/a | US$63m |
| Mar 31 2023 | n/a | n/a | US$600k |
| Dec 31 2022 | US$11m | US$440k | US$5m |
| Sep 30 2022 | n/a | n/a | US$17m |
| Jun 30 2022 | n/a | n/a | US$35m |
| Mar 31 2022 | n/a | n/a | US$45m |
| Dec 31 2021 | US$290k | n/a | US$17m |
| Sep 30 2021 | n/a | n/a | -US$29m |
| Jun 30 2021 | n/a | n/a | -US$30m |
| Mar 31 2021 | n/a | n/a | US$9m |
| Dec 31 2020 | US$259k | n/a | US$7m |
| Sep 30 2020 | n/a | n/a | US$29m |
| Jun 30 2020 | n/a | n/a | US$18m |
| Mar 31 2020 | n/a | n/a | US$5m |
| Dec 31 2019 | US$261k | n/a | US$12m |
Compensation vs Market: Jim's total compensation ($USD12.38M) is about average for companies of similar size in the US market ($USD12.73M).
Compensation vs Earnings: Jim's compensation has been consistent with company performance over the past year.
CEO
Jim Hollingshead (61 yo)
2.4yrs
Tenure
US$12,379,765
Compensation
Dr. James R. Hollingshead, also known as Jim, Ph.D. had been President of Sleep & Respiratory Care Business at ResMed Inc. since July 2020 until May 05, 2022 and served as its President of Sleep Business s...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.4yrs | US$12.38m | 0.025% $ 4.6m | |
| Group VP | 5.6yrs | US$1.44m | 0.0061% $ 1.1m | |
| Senior VP & CTO | 1.3yrs | US$2.37m | 0.014% $ 2.6m | |
| Senior VP & General Counsel | 5.7yrs | US$2.47m | 0.021% $ 3.9m | |
| Executive VP | 6.8yrs | US$3.14m | 0.024% $ 4.4m | |
| Executive VP | less than a year | no data | 0.00014% $ 25.7k | |
| Senior Vice President of Global Operations | 1.8yrs | no data | 0.0052% $ 957.5k | |
| Vice President of Investor Relations | 9.8yrs | no data | no data | |
| Senior VP of Regulatory Affairs | 1.9yrs | no data | 0.0044% $ 814.1k | |
| Senior Director of Corporate Communications | no data | no data | no data | |
| Senior Vice President of Sales & Customer Care | 9.8yrs | no data | no data | |
| Senior VP of Strategy & Corporate Development | less than a year | no data | no data |
2.4yrs
Average Tenure
52yo
Average Age
Experienced Management: PODD's management team is considered experienced (2.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 5.3yrs | US$12.38m | 0.025% $ 4.6m | |
| Independent Director | 2.8yrs | US$322.50k | 0.0040% $ 727.8k | |
| Independent Chairman | 10.3yrs | US$387.10k | 0.042% $ 7.7m | |
| Chairman of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Educator Advisory Board | no data | no data | no data | |
| Member of Educator Advisory Board | no data | no data | no data | |
| Member of Educator Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Educator Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | less than a year | no data | no data |
4.0yrs
Average Tenure
61yo
Average Age
Experienced Board: PODD's board of directors are considered experienced (4 years average tenure).